Skip to content

The frontotemporal syndrome in amyotrophic lateral sclerosis: screen, impact, imaging and pathology.

The frontotemporal syndrome in amyotrophic lateral sclerosis: screen, impact, imaging and pathology. - The frontotemporal syndrome in amyotrophic lateral sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44137
Enrollment
181
Registered
2013-04-10
Start date
2013-07-02
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

binnen zenuwstelsel aandoeningen: dementie van het frontotemporale type (FTD) amyotrophic lateral sclerosis (ALS) Motor neuron disease (MND)

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >= 18 years, speak Dutch fluently, have a proxy (partner, family member or close friend) who speaks Dutch fluently and is willing to fill in the questionnaires. Furthermore, ALS patients must have sporadic or familial (fALS), probable, probable-laboratory supported or definite ALS, as defined by the El Escorial criteria, with a symptom duration of less than 12 months. ALS-FTD and behaviour variant-FTD patients must have sporadic or familial, probable or definite bv-FTD, as defined by the Neary criteria and the revised criteria by Rascovsky et al.

Exclusion criteria

Exclusion criteria: Any neurological or psychiatric condition with cognitive impairment or behavioural changes, use of psychopharmaca, excessive alcohol intake, i.e. >= 5 drinks per day, forced vital capacity

Design outcomes

Secondary

MeasureTime frame
1. An estimate of the impact of ALS and the frontotemporal syndrome on the patient and their carers. 2. A brainbank of phenotyped ALS patients.

Primary

MeasureTime frame
1. A validated, short cognitive screening instrument for ALS patients. 2. Differences in structural and functional brain networks (connectivity measures) between patients with and without a frontotemporal syndrome.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)